Danish Drugmaker Hit With IP Suit Over Cancer Test
AsymmetRx Inc. and Harvard University have filed a patent infringement lawsuit accusing Danish drugmaker Dako Denmark AS of infringing patents related to the first U.S. Food and Drug Administration-approved diagnostic test...To view the full article, register now.
Already a subscriber? Click here to view full article